Drawing for PHARMACT HEALTHCARE

USPTO serial 90617649

PHARMACT HEALTHCARE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
PEREZ, STEVEN M
Law office
TMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with PHARMACT HEALTHCARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian P. Gregg

BRIAN P. GREGG MCNEES WALLACE & NURICK100 PINE STREETHARRISBURG, PA 17108UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Ocular pharmaceuticals; Chemical adjuvants for medical purposes; Dermatological preparations; Reagents for medical use; Capsules for medicines; Cholesterol reducers; Amino acid preparations for pharmaceutical use; Anti-bacterial preparations; Anti-cancer preparations of chemical origin; Clinical diagnostic reagents; Cardiovascular drugs used in myocardial infarction; Pharmaceutical preparations for treating the symptoms of radiation sickness; Cultures for veterinary use; Anti-inflammatory ointments; Chemicals for pharmaceutical use; Cardiovascular agents for medical purposes; Antibacterial pharmaceuticals; Enzyme preparations for medical purposes; Balms for pharmaceutical purposes; Diagnostic preparations for veterinary purposes; Chemico-pharmaceutical preparations; Pharmaceutical preparations for the treatment of cardiovascular disease; Enzyme preparations for veterinary purposes; Mouthwashes for medical purposes; Cardiovascular drugs used in angina pectoris; Pharmaceutical preparations acting on the central nervous system; Chemical preparations for the diagnosis of diabetes; Living cells for veterinary use; Medical diagnostic test strips; Cardiovascular drugs used in treating congestive heart failure (CHF); Pharmaceutical preparations for the prevention of diabetes; Pharmaceutical products for ophthalmological use; Test strips for measuring blood glucose levels; Antigens; Wadding for medical purposes; Amino acid preparations for medical purposes; Autonomic drugs for medical purposes; Pharmaceutical preparations for the prevention of disorders of the nervous system; Pharmaceutical preparations for treating hypoglycemia; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for the treatment of osteoporosis; Cultures for medical use; Lotions for pharmaceutical purposes; In vitro diagnostic preparations for medical use; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for the treatment of diseases of the metabolic system; Reagents for use in medical genetic testing; Diagnostic biomarker reagents for medical purposes; Bacteriological preparations for pharmaceutical use; Medicated skin creams; Pharmaceutical preparations and substances; Pharmaceutical preparations for the prevention of inflammatory diseases; Amino acid preparations for veterinary use; Autoantigens; Injectable pharmaceuticals; Pharmaceutical preparations for the treatment of Parkinson's disease; Pharmaceutical preparations for activating cellular function; Cotton wool for pharmaceutical purposes; Antibacterial pharmaceuticals; Bacterial preparations for medical purposes; Dragees; Antibiotics for human use; Drug delivery agents; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for human use; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical creams; Diagnostic reagents for medical use; Enzymes for veterinary purposes; Ophthalmologic preparations; Ferments for medical or veterinary use; Pharmaceutical preparations for the treatment of central nervous system diseases; Balms for medical purposes; Diagnostic agents for medical use; Hypolipidemic agents; Eye bandages for medical use; Anti-Inflammatory analgesic plasters; Amino acids for medical or veterinary purposes; Diagnostic chemical reagents for medical use; Burn relief medication; Living cells for medical use; Pharmaceuticals for the treatment of erectile dysfunction; Ophthalmologic preparations; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Amino acids for veterinary purposes; Reagents for analytical purposes; Diagnostic preparations and materials; Chemical preparations for medical purposes; Reagents for analytical purposes; Medicated skin lotions; Reagents for in-vitro laboratory use; Chemical reagents for medical use; Pharmaceutical preparations for the prevention of diseases of the nervous system; Pharmaceutical drugs; Antibodies; Mouth sprays for medical use; Chemico-pharmaceutical preparations; Bacterial preparations for medical and veterinary use; Candy, medicated; Mouthwashes for medical purposes; Cardiovascular pharmaceuticals; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations for treating arthritis; Pharmaceutical preparations; Antibiotics for veterinary use; Diagnostic chemical reagents for medical use; Cardiovascular drugs for use in treating hypertension; Pharmaceutical preparations for the treatment of hyperlipidemia; Medicinal healthcare preparations; Synthetic peptides for pharmaceutical purposes; Medical preparations; Gastrointestinal preparations; Capsules made of dendrimer-based polymers, for pharmaceuticals; Cachets for pharmaceutical purposes; Diagnostic substances for medical use; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Medical diagnostic reagents and assays for testing of body fluids; Reagents for use in analysis; Immunostimulants; Amino acids for medical purposes; Anti-inflammatory preparations; Enzymes for medical purposes; Pharmaceutical preparations for the treatment of diseases of the endocrine system; Chemical reagents for medical or veterinary purposes; Cultures of microorganisms for medical or veterinary use; Medicine; Diagnostic testing materials for medical use; Chemical preparations for testing blood for medical purposes; Diagnostic agents for pharmaceutical use; Tissue-regenerative pharmaceutical preparations; Immunoassay reagents for medical use; Pharmaceutical agents affecting peripheral nervous system; Culture media for veterinary use; Antiseptics; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical agents affecting sensory organs; Chemical preparations for pharmaceutical purposes; Reagents for use in diagnostic tests; Medicated creams; Reagents for in-vitro laboratory use; Chemical test reagents; Antibiotics; Ferments for pharmaceutical purposes; Eye drops; Immunotherapeutic agents for bacterial infections; Therapeutic creams; Pharmaceutical preparations for use in ophthalmology; Diagnostic agents for medical use; Diagnostic reagents for medical use; Injectable dermal fillers; Antihypertensives; Medicinal ointments; Pharmaceutical preparations for peripheral nervous system; PharmaceuticalsACTIVE—
010Genetic testing apparatus for medical purposes; Temperature sensing apparatus for medical use; Immunological analysers; Temperature sensitive testing instruments for medical use; Chromatographic instruments for medical use; Temperature indicator labels for medical purposes; Temperature measuring instruments for medical use; Receptacles for applying medicines; Patient monitoring instruments; Chromatographic columns for medical use; Containers especially made for medical waste; Chromatographic columns for analytical chromatography; Diagnostic testing instruments for use in immunoassay procedure; Immunoadsorption columns for therapeutic use; Diagnostic testing instruments for use in immunoassay procedure; Chromatogram analyzers for medical use; Medical analytical apparatus for medical purposes; Specimen cup holders; Diagnostic measuring apparatus for medical use; Diagnostic testing instruments for use in immunoassay procedure; Diagnostic apparatus for medical purposes; Testing apparatus for medical purposes; Apparatus for DNA and RNA testing for medical purposes; Gamma cameras for medical purposes; Light sources for medical use; Lancets; Measuring devices for medical use; Temperature sensitive testing instruments for medical use; Medical therapy instruments; Automated analyzers for body fluids; Chromatographic columns for medical use; Temperature sensitive testing instruments for medical use; Blood testing apparatus; Blood lancets; Pipetting instruments for medical use; Temperature monitors for medical use; Blood glucose testing apparatus; Gas analyzers for medical analysis; Lamps for use with medical instruments; Meters for body fluids; Light filters for medical use; Chromatography plates for medical use; Immunoadsorption columns for diagnostic use; Gas chromatography apparatus for medical use; Spittoons for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jun 23, 2022MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 23, 2022ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 10, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 16, 2021DOCKASSIGNED TO EXAMINER—
Jul 10, 2021MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 9, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 5, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance